维普期刊资源整合服务平台（V6.5）

169篇 您的检索式：作者名="Apperley"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013显示文摘	Michele Baccarani Michael W. Deininger Gianantonio Rosti Andreas Hochhaus Simona Soverini Jane F. Apperley Francisco Cervantes Richard E. Clark Jorge E. Cortes Fran?ois Guilhot Henrik Hjorth-Hansen Timothy P. Hughes Hagop M. Kantarjian Dong-Wook Kim Richa	2013	Blood2013，，6：	3
2	Characterisation of Ba(OH) 2 –Na 2 SO 4 –blast furnace slag cement-like composites for the immobilisation of sulfate bearing nuclear wastes显示文摘	Neda Mobasher Susan A. Bernal Oday H. Hussain David C. Apperley Hajime Kinoshita John L. Provis	2014	Cement and Concrete Research2014，，：	2
3	Further full-scale and model pressure measurements on a cantilever grandstand显示文摘	Pitsis N G Apperley L W	1991	Journal of Wind Engineering and Industrial Aerodynamics1991，38，：	1
4	Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelct-derived growth factor receptor beta显示文摘	Apperley JF Gardembas M Mela JV	2002	N Engl J Med2002，347，7：	1
5	Response to imatinibmesylate in patients with chronic myeloproliferative diseases withrearrangements of the platelet-derived growth factor receptor be-ta显示文摘	Apperley JF Gardembas M Melo JV	2002	N Engl J Med2002，347，：	1
6	Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index显示文摘	Terpos E Szydlo R Apperley JF	2003	Blood2003，102，3：	1
7	Issues of Imatinib and Pregnancy Outcome显示文摘	Apperley J		0，，10：	1
8	Kanemite(NaHSi2O5·3H2O)and its hydrogen-exchanged form显示文摘	Apperley David C Hudson Michael J Keene Matthew T J	1995	J Mater Chem1995，5，4：	1
9	Chronic myelogenous leukemia显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematology2003，，：	1
10	CML in pregnancy and childhood显示文摘	Apperley J		0，，03：	1
11	显示文摘	Adams P N Apperley D C Monkman A P	1993	Polymer1993，34，2：	1
12	How I treat leukemia dur- ing pregnaney显示文摘	Milojkovic D Apperley JF	2014	Blood2014，123，：	1
13	HLAB8and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of development of chronic myeloid leukemia显示文摘	Posthuma EF Falkenburg JH Apperley JF	1999	Blood1999，93，：	1
14	Poor adherence is the main reason for loss of CCyR and imatinib failure for chron- ic myeloid leukemia patients on long-term therapy 显示文摘	Ibrahim AR Eliasson L Apperley JF	2011	Blood2011，117，14：	1
15	HLA-DR4 ia associated with a diminished risk of the development of chronic myeloid leukemia (CML)显示文摘	Posthuma EFM Falkenburg JHF Apperley JF	2000	Leukemia2000，14，：	1
16	Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia显示文摘	WADHWA J SZYDLO RM APPERLEY JF	2002	Blood2002，99，7：	1
17	Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib 显示文摘	Cheah CY Burbury K Apperley JF	2014	Blood2014，123，23：	1
18	Part I:Meehanisms of Resistance to Imatinib in Chronic Myeloid Leukaemia显示文摘	Apperley JF	2007	Lancet Oncol2007，8，11：	1
19	Soluble re-ceptor activator of nuclear factor kB ligand-osteo-protegerin ratio predicts survival in multiple myelo-ma :proposal for a novel prognostic index 显示文摘	Terpos E Szydlo R Apperley JF	2003	Blood2003，102，3：	1
20	Chronic Myeloid Leukemia 显示文摘	Melo JV Hughes TP Apperley JF	2003	Hematology Am Soc Hematol Educ Program2003，2003，1：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示